HuagongsheHuagongshe Chemistry Print Report · For research reference only
Potassium Hydroxide → Potassium 4-[{[(4-fluorophenyl)methyl]imino}(hydroxy)methyl]-1-methyl-2-{2-[(5-methyl-1,3,4-oxadiazole-2-carbonyl)amino]propan-2-yl}-6-oxo-1,6-dihydropyrimidin-5-olate
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Potassium Hydroxide | HCID 14797 | — |
| Reactant | Raltegravir | HCID 54671008 | — |
| Solvent | 1,4-Dioxane | HCID 31275 | — |
| Product | Potassium 4-[{[(4-fluorophenyl)methyl]imino}(hydroxy)methyl]-1-methyl-2-{2-[(5-methyl-1,3,4-oxadiazole-2-carbonyl)amino]propan-2-yl}-6-oxo-1,6-dihydropyrimidin-5-olate | HCID 23668479 | — |
Reaction Steps
A flask (100 ml) was charged with Raltegravir free hydroxy (500 mg) completely dissolved in 1,4-dioxane (35 ml) at room temperature. A solution of 30% aqueous KOH (0.162 ml) was added. The resulting mixture was stirred for 24 h at room temperature. A solid precipitated and was filtered under reduced pressure to provide wet Raltegravir potassium crystalline Form VII.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08722722B2 |
| Source dataset | uspto-grants-2014_05 |
| ORD ID | ord-c55e3c55b1f647d6a97106ef4f683d57 |
| Source note | uspto-grants-2014_05 |